JP2024028391A5 - - Google Patents

Download PDF

Info

Publication number
JP2024028391A5
JP2024028391A5 JP2024000549A JP2024000549A JP2024028391A5 JP 2024028391 A5 JP2024028391 A5 JP 2024028391A5 JP 2024000549 A JP2024000549 A JP 2024000549A JP 2024000549 A JP2024000549 A JP 2024000549A JP 2024028391 A5 JP2024028391 A5 JP 2024028391A5
Authority
JP
Japan
Prior art keywords
ophthalmic composition
aqueous ophthalmic
sodium
group
total amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024000549A
Other languages
English (en)
Japanese (ja)
Other versions
JP7697068B2 (ja
JP2024028391A (ja
Filing date
Publication date
Priority claimed from JP2019089131A external-priority patent/JP7417365B2/ja
Application filed filed Critical
Publication of JP2024028391A publication Critical patent/JP2024028391A/ja
Publication of JP2024028391A5 publication Critical patent/JP2024028391A5/ja
Priority to JP2025097597A priority Critical patent/JP2025120387A/ja
Application granted granted Critical
Publication of JP7697068B2 publication Critical patent/JP7697068B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024000549A 2018-05-09 2024-01-05 水性眼科組成物 Active JP7697068B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025097597A JP2025120387A (ja) 2018-05-09 2025-06-11 水性眼科組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018090936 2018-05-09
JP2018090936 2018-05-09
JP2019089131A JP7417365B2 (ja) 2018-05-09 2019-05-09 水性眼科組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019089131A Division JP7417365B2 (ja) 2018-05-09 2019-05-09 水性眼科組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025097597A Division JP2025120387A (ja) 2018-05-09 2025-06-11 水性眼科組成物

Publications (3)

Publication Number Publication Date
JP2024028391A JP2024028391A (ja) 2024-03-04
JP2024028391A5 true JP2024028391A5 (enExample) 2024-05-15
JP7697068B2 JP7697068B2 (ja) 2025-06-23

Family

ID=68612917

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019089131A Active JP7417365B2 (ja) 2018-05-09 2019-05-09 水性眼科組成物
JP2024000549A Active JP7697068B2 (ja) 2018-05-09 2024-01-05 水性眼科組成物
JP2025097597A Pending JP2025120387A (ja) 2018-05-09 2025-06-11 水性眼科組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019089131A Active JP7417365B2 (ja) 2018-05-09 2019-05-09 水性眼科組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025097597A Pending JP2025120387A (ja) 2018-05-09 2025-06-11 水性眼科組成物

Country Status (1)

Country Link
JP (3) JP7417365B2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11766421B2 (en) 2017-09-25 2023-09-26 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
JP7277899B2 (ja) * 2018-12-26 2023-05-19 ジャパンメディック株式会社 液体組成物と、その液体組成物の発泡を抑制する方法及び発泡抑制剤
MX2021007709A (es) 2018-12-27 2021-12-15 Surface Ophthalmics Inc Composiciones farmacéuticas oftálmicas y procedimientos para el tratamiento de las enfermedades de la superficie ocular.
JP2020132536A (ja) * 2019-02-14 2020-08-31 参天製薬株式会社 クロモグリク酸又はその塩を含有する水性医薬組成物
JP7688990B2 (ja) * 2020-03-27 2025-06-05 ロート製薬株式会社 ソフトコンタクトレンズ用眼科組成物
CN117979951A (zh) 2021-05-10 2024-05-03 瑟菲斯眼科股份有限公司 一种用于缓解眼部疼痛的硫酸软骨素的用途
US12440510B2 (en) 2021-05-10 2025-10-14 Surface Ophthalmics, Inc. Use of chondroitin sulfate for relieving ocular pain
JP7178470B1 (ja) 2021-05-17 2022-11-25 ロート製薬株式会社 眼科組成物
EP4393496A4 (en) * 2021-10-29 2025-06-25 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
TW202519560A (zh) * 2023-09-06 2025-05-16 日商樂敦製藥股份有限公司 眼科組成物
TW202525308A (zh) * 2023-09-06 2025-07-01 日商樂敦製藥股份有限公司 眼科組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0977656A (ja) * 1995-09-14 1997-03-25 Toshihiro Handa 点眼用エアゾル組成物
JP4442118B2 (ja) * 2003-05-29 2010-03-31 ゼリア新薬工業株式会社 安定な点眼剤
JP4827385B2 (ja) * 2004-04-07 2011-11-30 ロート製薬株式会社 アズレン含有水性液剤
JP4904687B2 (ja) * 2004-11-25 2012-03-28 ゼリア新薬工業株式会社 眼科用組成物
JP4969052B2 (ja) * 2005-03-31 2012-07-04 小林製薬株式会社 眼科用組成物
JP2011136923A (ja) * 2009-12-28 2011-07-14 Lion Corp ソフトコンタクトレンズ用点眼剤
JP5834427B2 (ja) * 2010-03-11 2015-12-24 ライオン株式会社 ソフトコンタクトレンズへの吸着抑制方法
JP5838718B2 (ja) * 2010-10-29 2016-01-06 ライオン株式会社 ソフトコンタクトレンズ用眼科組成物及び吸着抑制方法
JP6150510B2 (ja) 2011-12-12 2017-06-21 ロート製薬株式会社 眼科用水性組成物
JP6186064B1 (ja) * 2016-08-09 2017-08-23 ロート製薬株式会社 眼科組成物
JP7288289B2 (ja) * 2016-11-11 2023-06-07 ロート製薬株式会社 水性眼科組成物

Similar Documents

Publication Publication Date Title
JP2024028391A5 (enExample)
JP2022107739A (ja) ロキソプロフェンを含有する医薬製剤（弐）
DE69932158D1 (de) Pharmazeutische zusammenstellungen
US5486509A (en) Method of preventing and treating chemotherapy-induced alopecia
JP2006528990A5 (enExample)
KR850004392A (ko) 경구투여용 장기작용 약제의 제조방법 및 조성물
EA200400664A1 (ru) Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii
JP2009519936A5 (enExample)
JP2014040481A (ja) 座瘡病変の治療のためのアダパレンと過酸化ベンゾイルとの組合せ
RU2015137145A (ru) Новые жидкие композиции с повышенной стабильностью
HU229502B1 (en) Use of epinastine in the treatment of allergic rithinis/conjuctivitis
JP7624538B2 (ja) 眼科組成物
SE9904413D0 (sv) Comminuted form
RU2012127776A (ru) Растворимые пленки, содержащие высокие концентрации неионных поверхностно-активных веществ, таких как полисорбаты, для увеличения высоких нагрузок твердых продуктов
SE448604B (sv) Farmaceutiskt preparat innehallande heparin, dextransulfat eller polyvinylsulfat samt zinkjoner
JP2001187733A5 (enExample)
JP2004068056A5 (enExample)
RU2006101686A (ru) Композиции для местного применения, восстанавливающие структуру ногтей
Anelli et al. Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs
BRPI0518781A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, e, uso de um composto
ME02149B (me) FORMULACIJE l METODE ZA LEČENJE AMILOIDOZE
JP2023112106A5 (enExample)
JP2011136923A (ja) ソフトコンタクトレンズ用点眼剤
US20050249802A1 (en) Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
CN109562041A (zh) 具有牛磺酸的固体清洁组合物和其方法